The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis (Q42666627)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2001
edit
Language Label Description Also known as
English
The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis
scientific article published on September 2001

    Statements

    The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis (English)
    1 September 2001
    153-158

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit